CA2581606A1 - Composition sans excipient pour le traitement de l'onychomycose - Google Patents

Composition sans excipient pour le traitement de l'onychomycose Download PDF

Info

Publication number
CA2581606A1
CA2581606A1 CA002581606A CA2581606A CA2581606A1 CA 2581606 A1 CA2581606 A1 CA 2581606A1 CA 002581606 A CA002581606 A CA 002581606A CA 2581606 A CA2581606 A CA 2581606A CA 2581606 A1 CA2581606 A1 CA 2581606A1
Authority
CA
Canada
Prior art keywords
composition
ingredients
carrier
mixture
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002581606A
Other languages
English (en)
Inventor
Muraleedharan G. Nair
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Michigan State University MSU
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2581606A1 publication Critical patent/CA2581606A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125—Camphor; Nuclear substituted derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CA002581606A 2004-09-24 2004-09-24 Composition sans excipient pour le traitement de l'onychomycose Abandoned CA2581606A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/031630 WO2006036144A1 (fr) 2004-09-24 2004-09-24 Composition sans excipient pour le traitement de l'onychomycose

Publications (1)

Publication Number Publication Date
CA2581606A1 true CA2581606A1 (fr) 2006-04-06

Family

ID=36119190

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002581606A Abandoned CA2581606A1 (fr) 2004-09-24 2004-09-24 Composition sans excipient pour le traitement de l'onychomycose

Country Status (4)

Country Link
EP (1) EP1796703A4 (fr)
JP (1) JP2008514596A (fr)
CA (1) CA2581606A1 (fr)
WO (1) WO2006036144A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1036661C2 (en) 2009-03-04 2010-09-07 Serrix B V Anti-fungal compounds & compositions.
DE202010012041U1 (de) 2010-08-31 2010-11-18 Sanderstrothmann Gmbh Zubereitung zur Nagelpflege
CN103893599A (zh) * 2014-04-12 2014-07-02 张军 一种治疗灰指甲的外用中药洗剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04154719A (ja) * 1990-10-19 1992-05-27 Hiroshi Kikuchi 水虫薬
AU3221497A (en) * 1997-05-30 1998-12-30 Procter & Gamble Company, The Disinfecting compositions and processes for disinfecting surfaces
JP2000128800A (ja) * 1998-10-16 2000-05-09 Hideyo Yamaguchi 水虫の感染予防および／又は治療法およびその器材
US6344190B1 (en) * 1999-02-08 2002-02-05 Board Of Trustees Of Michigan State University Method and compositions for treatment of fungal nail disease
US6436424B1 (en) * 2000-03-20 2002-08-20 Biosphere Medical, Inc. Injectable and swellable microspheres for dermal augmentation
JP2003073290A (ja) * 2001-08-31 2003-03-12 Kao Corp 外用剤組成物

Also Published As

Publication number Publication date
EP1796703A4 (fr) 2009-07-01
WO2006036144A1 (fr) 2006-04-06
AU2004323577A1 (en) 2006-04-06
EP1796703A1 (fr) 2007-06-20
JP2008514596A (ja) 2008-05-08
WO2006036144A8 (fr) 2007-06-14

Similar Documents

Publication Publication Date Title
Zhou et al. Chemical composition, antibacterial activity and study of the interaction mechanisms of the main compounds present in the Alpinia galanga rhizomes essential oil
US10946049B2 (en) Use of gram negative species to treat atopic dermatitis
Ramsewak et al. In vitro antagonistic activity of monoterpenes and their mixtures against ‘toe nail fungus’ pathogens
Khosravi et al. Zataria multiflora cream for the treatment of acute vaginal candidiasis
US7341747B2 (en) Carrier-free composition for the treatment of onychomycosis
Kotnik et al. Terbinafine hydrochloride treatment of Microsporum canis experimentally-induced ringworm in cats
US10653727B2 (en) Use of gram negative species to treat atopic dermatitis
Elghali et al. Unveiling the impact of selected essential oils on MRSA strain ATCC 33591: antibacterial efficiency, biofilm disruption, and staphyloxanthin inhibition
Ansari et al. Design and evaluation of topical herbal antifungal stick containing extracts of Rhinacanthus nasutus
Beniaich et al. Bin Jardan
CA2581606A1 (fr) Composition sans excipient pour le traitement de l'onychomycose
Gayatri et al. Novel thiazolinyl-picolinamide-based palladium (II) complex extenuates the virulence and biofilms of vulvovaginal candidiasis (VVC) causing Candida
WO2010132122A2 (fr) Compositions et produits contenant des agents antimicrobiens diol cycloaliphatique et procédés d'utilisation des compositions et produits
AU2004323577B2 (en) Carrier-free composition for the treatment of onychomycosis
CN115227592A (zh) 抑菌剂组合物及其应用
EP4213949A1 (fr) Utilisation d'une composition de préservation pour préserver l'eubiose du tissu cutané et du cuir chevelu
Bairagi et al. Identification of bacterial population from diabetic wound of mice to study the bactericidal efficacy of green synthesized silver nanoparticle by saraca asoca bark extract
CN112451406B (zh) 一种植物源多效组合物及其制备方法和应用
US10159708B2 (en) Method for the treatment of acne
Abdul-Hussain et al. Crude aqueous Proteus mirabilis extract with quorum sensing inhibitory activity can increase the susceptibility of multidrug resistant Pseudomonas aeruginosa to antimicrobials
ALAHMAD et al. In vitro antifungal activity of thyme oil against Candida albicans isolated from Nail fungus (Onychomycosis)
Morgan et al. Cryopreservation of Streptococcus mutans for microcalorimetry based applications
Mohammed et al. Evaluation of the effectiveness of aqueous and methanolic extracts of pomegranate peels against Acinetobacter baumannii bacteria isolated from patients hospitalized in intensive care in some hospitals in Basra Governorate
Shaqra et al. In vitro Inhibition of Candida Species by Aqueous Garlic Extract in Gel and Lotion: Problem of Stability
Al-Toma0T et al. The preparation and Evaluation of Some Metronidazole Formulations as Gels and The study of Their Medicinal Activities Against Pathogenetic Microorganisms Causing Dermatitides

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued